Business
Total Voting Rights Update
Total Voting Rights Update.
About this update from Oxford Biomedica Plc
[{"type":"text","content":"\n \nRNS Number : 7488K Oxford Biomedica PLC 30 June 2014 \n\n\n\n\n\nFOR IMMEDIATE RELEASE\n\n\n30 June 2014 \n\n\n\n\n \nOXFORD BIOMEDICA PLC\nTotal Voting Rights Update\n \nIn accordance with the FCA's Disclosure and Transparency Rules, Oxford BioMedica plc (LSE:OXB) confirms that the Company's issued share capital consists of 2,494,584,919 ordinary shares of 1p each, all with voting rights. No shares are held in treasury.\n \nThis figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.\n \n \n \n-Ends-\n \n\n\n\n\nFor further information, please contact:\n\n\n\n\n\n\n\n \nOxford BioMedica plc: \nJohn Dawson, Chief Executive Officer\nTim Watts, Chief Financial Officer\n\n\n \n \n \nTel: +44 (0)1865 783 000\n\n\n\n\n \n \n\n\n\n\n\n\n\nMedia Enquiries:\nMary-Jane Elliott/Emma Thompson/Matthew Neal \nConsilium Strategic Communications\n\n\nTel: +44 (0)20 3709 5700\n\n\n\n\n \nNotes to editors\nOxford BioMedica®\nOxford BioMedica plc (LSE: OXB) is a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs. The Company's technology platform includes a highly efficient LentiVector® gene delivery system, which has specific advantages for targeting diseases of the central nervous system and the eye; and a unique tumour antigen (5T4), which is an ideal target for anti-cancer therapy. Through in-house and collaborative research, Oxford BioMedica has a broad pipeline with current partners and licensees including Sanofi, Pfizer, Novartis, GlaxoSmithKline, MolMed, Sigma-Aldrich, Biogen Idec, Emergent BioSolutions, ImaginAb and Immune Design Corp. Further information is available at www.oxfordbiomedica.co.uk and www.oxbsolutions.co.uk.\n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange END TVRGCGDLGUDBGSR\n ","length":4314,"tagName":"div"}]